Invention Grant
US08934959B2 Physiological pharmacokinetic analysis for combined molecular MRI and dynamic PET imaging
有权
组合分子MRI和动态PET成像的生理药代动力学分析
- Patent Title: Physiological pharmacokinetic analysis for combined molecular MRI and dynamic PET imaging
- Patent Title (中): 组合分子MRI和动态PET成像的生理药代动力学分析
-
Application No.: US13000382Application Date: 2009-06-22
-
Publication No.: US08934959B2Publication Date: 2015-01-13
- Inventor: Dragos-Nicolae Peligrad
- Applicant: Dragos-Nicolae Peligrad
- Applicant Address: NL Eindhoven
- Assignee: Koninklijke Philips N.V.
- Current Assignee: Koninklijke Philips N.V.
- Current Assignee Address: NL Eindhoven
- International Application: PCT/IB2009/052679 WO 20090622
- International Announcement: WO2010/004464 WO 20100114
- Main IPC: A61B5/055
- IPC: A61B5/055 ; G01R33/56 ; A61K49/18 ; A61K51/12 ; G01R33/48

Abstract:
Magnetic resonance (MR) imaging typically has excellent spatial resolution, but relatively poor temporal resolution. In contrast, positron emission tomography (PET) typically has excellent temporal resolution, but poor spatial resolution relative to MR. Resultantly, it is advantageous to use combined PET-MR imaging sequences to create hybrid or enhanced images that reap the benefits of both modalities. A contrast agent (80) that includes both a PET tracer (82) and MR contrast enhancement (86) can be used in such a combined modality setting. The contrast agent (80) also includes a targeting system (84) that allows the contrast agent (80) to pool in a region of interest.
Public/Granted literature
- US20110105892A1 PHYSIOLOGICAL PHARMACOKINETIC ANALYSIS FOR COMBINED MOLECULAR MRI AND DYNAMIC PET IMAGING Public/Granted day:2011-05-05
Information query